CASC11 also upregulates E2F1 expression through recruitment of eukaryotic translation initiation factor 4A3 (EIF4A3), activating the NF-κB and PI3K/AKT/mTOR pathways to promote HCC progression. The gene discussed is AKT1; the disease is hepatocellular carcinoma.